PRLD
Prelude Therapeutics Incorporated · Healthcare
3.68
6.36%(+0.22)
Prev. Close3.95
7.34%(+0.27)
Pre-marketLast Updated: — ET
52W L: $0.6152W H: $4.22
$3.78
CHG+0.32 (+9.25%)
H$4.00
L$2.86
VOL4.1M
PRLD (1h)
Prelude Therapeutics Incorporated · Healthcare
| 2023-12 |
| -107.1M |
| 25.6M |
| -3.5M |
| -110.6M |
| -136.2M |
| 2022-12 | -83.7M | 25.1M | -3M | -86.7M | -111.9M |
| 2021-12 | -83.5M | 20.9M | -2.3M | -85.9M | -106.8M |
Brusky Sean P.
officer: Chief Business Officer
0 SH @ $0.00
2026-03-05
Brusky Sean P.
officer: Chief Business Officer
275,000 SH @ $0.00
2026-03-05
Combs Andrew
officer: Chief Chemistry Officer
230,000 SH @ $2.30
2026-02-04
Scherle Peggy
officer: Chief Scientific Officer
230,000 SH @ $2.30
2026-02-04
Lim Bryant David
officer: CLO, CFO, Corp Sec.
275,000 SH @ $2.30
2026-02-04
Vaddi Krishna
director, officer: CEO
837,000 SH @ $2.30
2026-02-04
Sandor Victor
director
121,285 SH @ $1.39
2025-11-05
Dorton Katina
0 SH @ $0.00
2025-10-17